Related Experiment Video
Updated: Sep 3, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hypoglycemia and Factitious Disorders: A Case Report and Review
1Internal Medicine, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, USA.
Severe hypoglycemia can stem from factitious disorder, where patients intentionally ingest sulfonylureas like glipizide. This case highlights the importance of diagnostic testing for surreptitious drug use in unexplained hypoglycemia.
Area of Science:
- Endocrinology
- Psychiatry
Background:
- Hypoglycemia presents with diverse symptoms, and its differential diagnosis includes factitious disorders involving surreptitious insulin or secretagogue use.
- Distinguishing exogenous insulin from endogenous hyperinsulinemic hypoglycemia is crucial, but sulfonylurea ingestion can mimic insulinoma findings.
Observation:
- A patient with comorbidities presented with severe hypoglycemia and altered consciousness.
- Initial labs suggested endogenous hyperinsulinism, but a serum panel detected glipizide, an unprescribed sulfonylurea.
Findings:
- The patient was diagnosed with factitious disorder, with hypoglycemia attributed to surreptitious glipizide ingestion as a healthcare-seeking behavior.
- This case underscores the diagnostic challenges in identifying iatrogenic hypoglycemia caused by factitious drug administration.
Implications:
- Accurate diagnosis of hypoglycemia is vital due to significant patient morbidity.
- Managing factitious disorder requires integrated clinical and ethical approaches, particularly concerning surreptitious medication use.
More Related Videos
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...